Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers
- PMID: 16011390
- DOI: 10.1037/0893-164X.19.2.192
Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers
Abstract
In a 2 (patch) x 2 (smoking) x 2 (anxiety) mixed design, 52 undergraduate smokers randomly received a nicotine (21 mg) or placebo patch. After a 4-hr nicotine absorption/deprivation period, participants imagined several scenarios varying in cue content: (a) anxiety plus smoking, (b) anxiety, (c) smoking, and (d) neutral. Although smoking urge increased in both the nicotine and placebo conditions after the absorption/deprivation period, those who received the placebo reported significantly greater urge. During the cue reactivity trials, a significant Patch x Smoking x Anxiety interaction effect was observed for urge. However, participants who received nicotine still experienced moderate urges, indicating that nicotine did not attenuate cue-elicited urge. Transdermal nicotine did not diminish anxiety during the absorption/deprivation period or in response to the cues.
Copyright 2005 APA, all rights reserved.
Similar articles
-
Transdermal nicotine during cue reactivity in adult smokers with and without anxiety disorders.Psychol Addict Behav. 2012 Sep;26(3):507-18. doi: 10.1037/a0028828. Epub 2012 Jun 11. Psychol Addict Behav. 2012. PMID: 22686966 Free PMC article. Clinical Trial.
-
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.Exp Clin Psychopharmacol. 2007 Feb;15(1):81-92. doi: 10.1037/1064-1297.15.1.81. Exp Clin Psychopharmacol. 2007. PMID: 17295587 Clinical Trial.
-
Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019. Clin Ther. 2008. PMID: 18803988 Clinical Trial.
-
The relevance and treatment of cue-induced cravings in tobacco dependence.J Subst Abuse Treat. 2009 Apr;36(3):235-43. doi: 10.1016/j.jsat.2008.06.005. Epub 2008 Aug 20. J Subst Abuse Treat. 2009. PMID: 18715743 Review.
-
[Alternative method of smoking cessation--reduce to stop].Przegl Lek. 2006;63(10):1108-10. Przegl Lek. 2006. PMID: 17288230 Review. Polish.
Cited by
-
Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development.J Addict Res Ther. 2019;10(2):381. Epub 2019 Apr 15. J Addict Res Ther. 2019. PMID: 31404286 Free PMC article.
-
Counterbalancing in smoking cue research: a critical analysis.Nicotine Tob Res. 2010 Nov;12(11):1068-79. doi: 10.1093/ntr/ntq159. Epub 2010 Sep 30. Nicotine Tob Res. 2010. PMID: 20884695 Free PMC article. Review.
-
Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.Addict Behav. 2017 Aug;71:18-24. doi: 10.1016/j.addbeh.2017.02.018. Epub 2017 Feb 10. Addict Behav. 2017. PMID: 28235705 Free PMC article. Clinical Trial.
-
Neural substrates of abstinence-induced cigarette cravings in chronic smokers.J Neurosci. 2007 Dec 19;27(51):14035-40. doi: 10.1523/JNEUROSCI.2966-07.2007. J Neurosci. 2007. PMID: 18094242 Free PMC article.
-
Transdermal nicotine during cue reactivity in adult smokers with and without anxiety disorders.Psychol Addict Behav. 2012 Sep;26(3):507-18. doi: 10.1037/a0028828. Epub 2012 Jun 11. Psychol Addict Behav. 2012. PMID: 22686966 Free PMC article. Clinical Trial.